Small heterodimer partner deletion prevents hepatic steatosis and when combined with farnesoid X receptor loss protects against type 2 diabetes in mice-Reference-Cited by-同舟云学术

Small heterodimer partner deletion prevents hepatic steatosis and when combined with farnesoid X receptor loss protects against type 2 diabetes in mice

Published:2017-10-30 Issue:6 Volume:66 Page:1854-1865
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Akinrotimi Oludemilade¹,Riessen Ryan¹,VanDuyne Philip¹,Park Jung Eun²,Lee Yoon Kwang²,Wong Lee-Jun³,Zavacki Ann M.⁴,Schoonjans Kristina⁵,Anakk Sayeepriyadarshini¹

Affiliation:

1. Department of Molecular and Integrative Physiology; University of Illinois, Urbana-Champaign; Urbana IL

2. Department of Integrative Medical Sciences; Northeast Ohio Medical University; Rootstown OH

3. Department of Molecular and Human Genetics; Baylor College of Medicine; Houston TX

4. Department of Medicine, Brigham and Women's Hospital; Harvard Medical School; Boston MA

5. Laboratory of Metabolic Signaling, Institute of Bioengineering; Ecole Polytechnique Fédérale de Lausanne; Lausanne Switzerland

Funder

University of Illinois at Urbana-Champaign

NICHD

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.29305/fullpdf

Reference50 articles.

1. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity;Browning;Hepatology,2004

2. Human fatty liver disease: old questions and new insights;Cohen;Science,2011

3. Mechanisms for insulin resistance: common threads and missing links;Samuel;Cell,2012

4. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes;Perry;Nature,2014

5. Nuclear receptors and the control of metabolism;Francis;Annu Rev Physiol,2003

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Profile of the bile acid FXR-FGF15 pathway in the glucolipid metabolism disorder of diabetic mice suffering from chronic stress;PeerJ;2023-11-15

2. Hepatocyte-specific Sox9 knockout ameliorates acute liver injury by suppressing SHP signaling and improving mitochondrial function;Cell & Bioscience;2023-08-30

3. Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic FXR-SHP-SREBP1C/PPARα/CD36 pathway;European Journal of Pharmacology;2023-08

4. Transgenic mice lacking FGF15/19-SHP phosphorylation display altered bile acids and gut bacteria, promoting nonalcoholic fatty liver disease;Journal of Biological Chemistry;2023-08

5. Pathological bile acid concentrations in chronic cholestasis cause adipose mitochondrial defects;JHEP Reports;2023-05